Adenosine levels in the exhaled breath condensate: a potential surrogate marker of airway inflammation

Spicuzza L., Di Maria G.U., Polosa R.

Source: Eur Respir J 2003; 22: 392
Journal Issue: August
Disease area: Airway diseases

PDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Spicuzza L., Di Maria G.U., Polosa R.. Adenosine levels in the exhaled breath condensate: a potential surrogate marker of airway inflammation. Eur Respir J 2003; 22: 392

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Markers of airway diseases in exhaled breath condensate and their clinical value
Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases
Year: 2013


Exhaled breath condensate pH standardised for CO2 partial pressure
Source: Eur Respir J 2007; 29: 496-501
Year: 2007



Nitrite concentration in exhaled breath condensate correlates with markers of lung overdistension in COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 317s
Year: 2004

Adenosine in exhaled breath condensate in healthy volunteers and in patients with asthma
Source: Eur Respir J 2002; 20: 1393-1398
Year: 2002



Prediction of CF exacerbations by FeNO and non-invasive inflammatory markers in exhaled breath condensate
Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation
Year: 2008


Monitoring airway inflammation after allergen challenge by measuring 8-isoprostane in exhaled breath condensate
Source: Annual Congress 2010 - Biomarkers and diagnosis of allergic inflammatory diseases
Year: 2010

Adenosine level in exhaled breath increases during exercise-induced bronchoconstriction
Source: Eur Respir J 2005; 25: 873-878
Year: 2005



Noninvasive assessment of airway inflammation in asthma
Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=164
Year: 2003

Cystenil-leukotrienes as markers of airway inflammation in exhaled breath condensate of asthmatic children
Source: Eur Respir J 2002; 20: Suppl. 38, 412s
Year: 2002

Comparison between exhaled and sputum oxidative stress biomarkers in chronic airway inflammation
Source: Eur Respir J 2004; 24: 1011-1017
Year: 2004



Ozone-induced airway inflammation and its attenuation by corticosteroids are detectable in sputum samples but not in exhaled breath condensate
Source: Eur Respir J 2004; 24: Suppl. 48, 577s
Year: 2004

Increased nitrosative stress in COPD airways: validation and measurement in exhaled breath condensate
Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment
Year: 2009

Exhaled breath condensate: 8-isoprostane and eicosanoids
Source: Eur Respir Monogr 2010; 49: 196-206
Year: 2010


Periostin in exhaled breath condensate as a biomarker of different severe asthma phenotypes.
Source: International Congress 2017 – Systemic and airway biomarkers
Year: 2017


Relationship between acidity of exhaled breath condensate, lung function and airway inflammation in asthmatic children
Source: Annual Congress 2007 - Assessing asthma severity and control in children
Year: 2007